Location of pharmaceutical innovation: 2000–2009

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Normalized locations of drug patent inventors by region.
Figure 2: Locations of drug patent inventors by country for the top ten countries.


  1. 1

    Hughes, B. Evolving R&D for emerging markets. Nature Rev. Drug Discov. 9, 417–420 (2010).

  2. 2

    National Science Foundation. Division of Science Resources Statistics. Asia's Rising Science and Technology Strength: Comparative Indicators for Asia, the European Union, and the United States. National Science Foundation website [online], (2007).

  3. 3

    Organisation for Economic Co-operation and Development (OECD). Education at a Glance 2009: OECD Indicators 1–472 (OECD Publishing, Paris, 2009).

  4. 4

    National Science Foundation. Doctorate Recipients from U. S. Universities: Summary Report 2007–08. National Science Foundation website [online], (2009).

  5. 5

    National Science Foundation. National Science Board: Science and Engineering Indicators 2010. National Science Foundation website [online], (2010).

  6. 6

    IMS Health. IMS Market Prognosis. (IMS Health, March 2009).

  7. 7

    US Department of Commerce, United States Patent and Trademark Office. Manual of Patent Examining Procedure (US Patent and Trademark Office, Virginia, 2010).

  8. 8

    Light, D. W. Global drug discovery: Europe is ahead. Health Aff. 28, 969–977 (2009).

Download references

Author information

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Friedman, Y. Location of pharmaceutical innovation: 2000–2009. Nat Rev Drug Discov 9, 835–836 (2010) doi:10.1038/nrd3298

Download citation

Further reading